IL6 and cancer: Interleukin 6 (IL-6), a cytokine that is produced during acute and chronic inflammation, triggers several signalling cascades in cancer that affect cell proliferation and survival, the inhibition of apoptosis, and the induction of anti-cancer drug resistance.